Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma. Sci Rep. 2016 09 13; 6:32992.
View in:
PubMed
subject areas
Aminopyridines
Animals
Antineoplastic Agents
Apoptosis
Bridged Bicyclo Compounds, Heterocyclic
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Movement
Cell Proliferation
Drug Synergism
Female
Humans
Lung Neoplasms
Mesothelioma
Mice
Mice, Nude
Microtubules
Morpholines
Pleural Neoplasms
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-met
Pyrazoles
Pyridines
Pyrimidines
Signal Transduction
Xenograft Model Antitumor Assays
authors with profiles
Ravi Salgia
Hedy Kindler